U.S. Lyme Disease Diagnostic Devices Market: Improving Accuracy and Speed of Diagnosis

The U.S. lyme disease diagnostic devices market size accounted for USD 750.20 million in 2024 and is expected to exceed around USD 1,318.36 million by 2034, growing at a CAGR of 5.8% from 2025 to 2034.

U.S. Lyme Disease Diagnostic Devices Market Report Highlights

• By product, the serological test segment has held the largest revenue share in 2024.
• By product, the lymphocytic transformation tests segment is anticipated to expand at a significant CAGR during the projected period.
• By end user, the hospitals segment has held the largest revenue share in 2024.
• By end user, the public/private laboratories segment is set to experience the fastest rate of market growth from 2025 to 2034.

The U.S. Lyme disease diagnostic devices market is an emerging market that is concerned with the manufacturing of devices that can help with the diagnosis of Lyme disease. It involves different kinds of tests and procedures that help in detecting Lyme disease early on and also accurately. Lyme is a tick-borne disease, and it causes symptoms such as fever, rash, headache, etc., in the body. If not detected early and treated effectively, it may spread to the joints and then may affect the entire nervous system.

There are many different factors that work together efficiently to drive the U.S. Lyme disease diagnostic devices market. However, there are three major factors that primarily contribute more toward increasing the market’s growth. These three drivers in the U.S. Lyme disease diagnostic devices market are the rise in tick population in the region, increased investment in research and development, and technological advancements. Lyme disease is caused by the bacteria Borrelia burgdorferi, which is transmitted by the black-legged tick (Ixodes scapularis). A rise in tick population is being observed, attributed to climate change, which is creating warmer, wetter environments. This is ideal for ticks to thrive, leading to their spread into the Midwest and to areas of higher elevation in Western United States. A rise in the number of people being diagnosed with Lyme disease is increasing day by day. The population that has more ticks around or other animals that may house ticks is also rising in the country. The increase in the diagnosis of Lyme disease has led to a significant increase in the demand for Lyme disease diagnostic devices. Such an event leads to an increase in the customer base, as the number of patients increases, so does their demand for treatment procedures increases.

Another one of the major driving forces in the U.S. Lyme disease diagnostic devices market is the advancement in technology. With innovative ideas and techniques, there is a new kind of efficiency found in the treatment procedures. There is also an increase in research and development, due to which there is a higher scope for improvement as well as development in the endoscopes market. Advancements in technology have led to improved systems that help in providing real-time monitoring.

Nonetheless, except for the ones mentioned here, many other factors help in driving the growth of the U.S. Lyme disease diagnostic devices market. These include improvements in healthcare infrastructure, support from the government for spending on healthcare, and an increase in public awareness regarding diseases spread through insect bites. Artificial intelligence has now become a great way to get things done easily and is easily available at one’s fingertips. It is also greatly contributing to driving the growth of the U.S. Lyme disease diagnostic devices market. With the integration of artificial intelligence and manufacturing processes, there is a significant increase in production rates.

Artificial intelligence not only helps with the optimization of manufacturing processes but also replaces time-consuming tasks like analyzing complex data and predictive analysis. AI has proved to be very useful in analyzing large amounts of data, which has led to quicker development of treatment processes. Almost every step in this process is optimized using artificial intelligence. With the integration of artificial intelligence and the manufacturing process, the market ensures smooth and quick treatment procedures tailored to suit the patient’s preferences.

The U.S. Lyme disease diagnostic devices market is expected to expand and grow in a few years with the introduction of advanced technology and mechanization. Some new and upcoming drivers in the market will grow as well as expand all over the globe. These include factors such as a growing number of people being diagnosed with Lyme disease, growth in the medical and healthcare industry, and technical advancements in the medical field.